| |
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents
Int J Cardiol, 2010. 139(1): p. 80-91.
G. Niccoli, et al., |
| |
Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry
J Invasive Cardiol, 2009. 21(10): p. 532-7.
F. Burzotta, et al., |
| |
Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study
Circ Cardiovasc Interv, 2009. 2(1): p. 27-34.
A. Erglis, et al., |
| |
Intervention for jailed diagonal branch is not necessary while stenting the left anterior descending artery
J Interv Cardiol, 2009. 22(3): p. 252-6.
N. Ikeda, et al., |
| |
Double versus single stenting for coronary bifurcation lesions: a meta-analysis
Circ Cardiovasc Interv, 2009. 2(5): p. 409-15.
D. G. Katritsis, G. C. Siontis and J. P. Ioannidis, |
| |
Physiologic evaluation of bifurcation lesions using fractional flow reserve
J Interv Cardiol, 2009. 22(2): p. 110-3.
B. K. Koo, |
| |
Interventional therapy of bifurcation lesions: a TIMI flow-guided concept to treat side branches in bifurcation lesions--a prospective randomized clinical study (Thueringer bifurcation study, THUEBIS study as pilot trial)
Circ Cardiovasc Interv, 2009. 2(6): p. 535-42.
H. V. Korn, et al., |
| |
Quantitative angiographic methods for bifurcation lesions: a consensus statement from the European Bifurcation Group
Catheter Cardiovasc Interv, 2009. 73(2): p. 258-66.
A. Lansky, et al., |
| |
Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology
Eur Heart J, 2009. 30(17): p. 2087-94.
T. Palmerini, et al., |
| |
Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology
Eur Heart J, 2009. 30(17): p. 2087-94.
T. Palmerini, et al., |
| |
Evaluation of a bifurcation drug-eluting stent system versus provisional T-stenting in a perfused synthetic coronary artery model
J Interv Cardiol, 2009. 22(6): p. 537-46.
D. G. Rizik, et al., |
| |
Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions
Catheter Cardiovasc Interv, 2009. 74(2): p. 313-20.
I. Sheiban, et al., |
| |
Three-year outcome of drug-eluting stent implantation for coronary artery bifurcation lesions
Catheter Cardiovasc Interv, 2009.
C. T. Stinis, et al., |
| |
Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial
Catheter Cardiovasc Interv, 2009. 73(7): p. 890-7.
N. Suzuki, et al., |
| |
9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study
J Am Coll Cardiol, 2009. 53(12): p. 1031-9.
S. Verheye, et al., |
| |
Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions
Catheter Cardiovasc Interv, 2009. 74(1): p. 76-84.
H. M. Yang, et al., |
| |
Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow
Circulation, 2010. 121(1): p. 132-42.
A. Zampetaki, et al., |
| |
Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: a meta-analysis of randomised trials
Heart, 2009. 95(20): p. 1676-81.
F. Zhang, L. Dong and J. Ge, |
| |
| |
| |
 |